Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials
T Nagano, M Katsurada, Y Yasuda… - Therapeutic …, 2019 - journals.sagepub.com
Smoking causes various diseases and is a major public health threat worldwide. Therefore,
promoting smoking cessation is the most important intervention contributing to maintaining …
promoting smoking cessation is the most important intervention contributing to maintaining …
Smoking cessation–recent advances
JJ McNeil, L Piccenna, LL Ioannides-Demos - Cardiovascular drugs and …, 2010 - Springer
Background Smoking continues to be a major contributor to the burden of disease across
the world although there has been a decrease in some developed countries such as USA …
the world although there has been a decrease in some developed countries such as USA …
Current approaches to pharmacotherapy for smoking cessation
K Suchanek Hudmon, RL Corelli… - … in respiratory disease, 2010 - journals.sagepub.com
It is well established that smoking is the primary preventable cause of disease and death in
the United States and that it is responsible for a wide range of negative health …
the United States and that it is responsible for a wide range of negative health …
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis
Background Smoking remains the leading preventable cause of premature deaths. Several
pharmacological interventions now exist to aid smokers in cessation. These include Nicotine …
pharmacological interventions now exist to aid smokers in cessation. These include Nicotine …
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials
MJ Eisenberg, KB Filion, D Yavin, P Bélisle, S Mottillo… - Cmaj, 2008 - Can Med Assoc
Background: Many placebo-controlled trials have demonstrated the efficacy of individual
pharmacotherapies approved for smoking cessation. However, few direct or indirect …
pharmacotherapies approved for smoking cessation. However, few direct or indirect …
Smoking cessation intervention: an evidence-based approach
R Laniado-Laborin - Postgraduate medicine, 2010 - Taylor & Francis
Cigarette smoking represents the most important source of preventable morbidity and
premature mortality worldwide. Approximately 100 million deaths were caused by tobacco …
premature mortality worldwide. Approximately 100 million deaths were caused by tobacco …
[HTML][HTML] Recent updates of pharmacotherapy for smoking cessation
JS Hwang, CM Lee - Korean Journal of Family Practice, 2021 - kjfp.or.kr
The use of tobacco, cigarette smoking in particular, is a leading causal factor of countless
deaths and disabilities worldwide. Its widespread prevalence is a major global concern and …
deaths and disabilities worldwide. Its widespread prevalence is a major global concern and …
Combination bupropion SR and varenicline for smoking cessation: a systematic review
T Vogeler, C McClain, KE Evoy - The American Journal of Drug …, 2016 - Taylor & Francis
Background: Tobacco is the leading cause of preventable death in the world. Current
cessation medications include nicotine replacement therapy (NRT), varenicline, and …
cessation medications include nicotine replacement therapy (NRT), varenicline, and …
Non-nicotinic therapies for smoking cessation
ECK Siu, RF Tyndale - Annu. Rev. Pharmacol. Toxicol., 2007 - annualreviews.org
Cigarette smoking is the primary cause of numerous preventable diseases; as such, the
goals of smoking cessation are both to reduce health risks and to improve the quality of life …
goals of smoking cessation are both to reduce health risks and to improve the quality of life …
Update on pharmacologic and nonpharmacologic therapies for smoking cessation
J Schmelzle, WW Rosser, R Birtwhistle - Canadian Family Physician, 2008 - cfp.ca
ABSTRACT OBJECTIVE To review the evidence on the efficacy and safety of pharmacologic
and nonpharmacologic therapies for smoking cessation. QUALITY OF EVIDENCE …
and nonpharmacologic therapies for smoking cessation. QUALITY OF EVIDENCE …